ORAGENICS INC
Biotech developing intranasal drugs for concussion and other brain disorders.
OGEN | NYSE
Overview
Corporate Details
- ISIN(s):
- US6840233026
- LEI:
- Country:
- United States of America
- Address:
- 1990 MAIN STREET, 34236 SARASOTA
- Website:
- https://www.oragenics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oragenics, Inc. is a development-stage biotechnology company specializing in the development of therapeutics for neurological conditions. The company focuses on a proprietary intranasal drug delivery platform designed to enable targeted, non-invasive treatments for brain-related disorders. Its lead product candidate, ONP-002, is being advanced as a potential treatment for concussion. Beyond concussion, Oragenics' platform technology has potential applications for addressing other neurodegenerative diseases and central nervous system (CNS) disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ORAGENICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ORAGENICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ORAGENICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
